We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here


Increase in incidence of advanced prostate cancer

Friday, May 12, 2017

Jim C. Hu, M.D., professor of Urology, spoke to OncLive about the increase in the incidence of advanced prostate cancer in the United States. There is considerable controversy regarding prostate-specific antigen (PSA) testing for patients with prostate cancer, explains Hu.

The United States Preventive Services Task Force recommends against PSA screening for patients with prostate cancer regardless of age. Given some of the recent guidelines that were developed by the Task Force due the decrease of prostate cancer screening, many are questioning if the current presentation of prostate cancer is changing, states Hu.